As the US has no national SARS-CoV-2 genome sequencing program, it is unable to spot where in the country a recently identified viral strain may be circulating or keep an eye out for new, emerging viral variants, the New York Times writes.
As the US has no national SARS-CoV-2 genome sequencing program, it is unable to spot where in the country a recently identified viral strain may be circulating or keep an eye out for new, emerging viral variants, the New York Times writes.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.